{"disease":{"id":"male-breast-carcinoma","name":"male breast carcinoma"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06805812","title":"Predicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advanced Hormone REceptor-poSitive HER2-negative Breast Cancer: the Retrospective-prospective Multicenter Italian PALMARES-2 Study","phase":"","overall_status":"RECRUITING","enrollment_count":3500,"lead_sponsor_name":"Fondazione IRCCS Istituto Nazionale dei Tumori, Milano","has_results":false},{"nct_id":"NCT05564377","title":"Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":2900,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT06422455","title":"Access to Genetic Testing in Underserved Patients With Cancer","phase":"NA","overall_status":"RECRUITING","enrollment_count":800,"lead_sponsor_name":"University of Southern California","has_results":false},{"nct_id":"NCT05263362","title":"An Integrated Optimization of Surgery and Radiotherapy Techniques to Improve Cosmetic Outcome and Quality of Life in Breast Conserving Therapy for Breast Cancer Patients (STARLINGS Study)","phase":"","overall_status":"COMPLETED","enrollment_count":775,"lead_sponsor_name":"Erasmus Medical Center","has_results":false},{"nct_id":"NCT01230346","title":"Culturally-Informed Counseling in Latinas at High Risk for Hereditary Breast or Ovarian Cancer","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":493,"lead_sponsor_name":"City of Hope Medical Center","has_results":false},{"nct_id":"NCT00861705","title":"Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed by Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":454,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":true},{"nct_id":"NCT06439940","title":"Oncoliq: Early Breast Cancer Detection Based on Liquid Biopsies and microRNAs","phase":"","overall_status":"RECRUITING","enrollment_count":364,"lead_sponsor_name":"Oncoliq US Inc","has_results":false},{"nct_id":"NCT00770809","title":"Paclitaxel and Trastuzumab With or Without Lapatinib in Treating Patients With Stage II or Stage III Breast Cancer That Can Be Removed by Surgery","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":305,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":true},{"nct_id":"NCT07331506","title":"Validation of the Oncoliq Test for the Early Detection of Breast Cancer.","phase":"","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Oncoliq US Inc","has_results":false},{"nct_id":"NCT05982496","title":"18F FES-PET/MRI for Tailoring Treatment of Luminal a and Lobular Breast Cancer","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":221,"lead_sponsor_name":"Università Vita-Salute San Raffaele","has_results":false},{"nct_id":"NCT01552434","title":"Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease","phase":"PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":155,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT03250676","title":"Trial of H3B-6545, in Women With Locally Advanced or Metastatic Estrogen Receptor-positive, HER2 Negative Breast Cancer","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":151,"lead_sponsor_name":"Eisai Inc.","has_results":true},{"nct_id":"NCT04245657","title":"Factors Affecting Functionality in Breast Cancer Survivors","phase":"","overall_status":"COMPLETED","enrollment_count":111,"lead_sponsor_name":"Izmir Bakircay University","has_results":false},{"nct_id":"NCT03518242","title":"Molecular Profile of Breast Cancer in Ugandan Patients With Stage IIB-III Breast Cancer","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"Fred Hutchinson Cancer Center","has_results":false},{"nct_id":"NCT03113825","title":"Study of AVB-620 in Women With Primary, Nonrecurrent Breast Cancer Undergoing Surgery","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":92,"lead_sponsor_name":"Avelas Biosciences, Inc.","has_results":false},{"nct_id":"NCT06246084","title":"INTENT Pilot Study - Enhancing Adherence Intentions to Endocrine Therapy","phase":"NA","overall_status":"COMPLETED","enrollment_count":76,"lead_sponsor_name":"Dana-Farber Cancer Institute","has_results":false},{"nct_id":"NCT05501704","title":"ETHAN - ET for Male BC","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"Jose Pablo Leone","has_results":false},{"nct_id":"NCT01349959","title":"Azacitidine and Entinostat in Treating Patients With Advanced Breast Cancer","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":58,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":true},{"nct_id":"NCT06176261","title":"DATO-BASE: DATOpotamab-deruxtecan for Breast Cancer Brain metAstaSEs","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":58,"lead_sponsor_name":"Sarah Sammons, MD","has_results":false},{"nct_id":"NCT00699491","title":"Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":48,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":true},{"nct_id":"NCT01145430","title":"Veliparib and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer or Metastatic Breast Cancer","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":45,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT05092373","title":"Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":43,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT01624441","title":"Dinaciclib and Epirubicin Hydrochloride in Treating Patients With Metastatic Triple-Negative Breast Cancer","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT02942355","title":"Trial of Anastrozole and Palbociclib in Metastatic HER2-Negative Breast Cancer","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":40,"lead_sponsor_name":"Wake Forest University Health Sciences","has_results":false},{"nct_id":"NCT03387553","title":"HER2 Directed Dendritic Cell Vaccine During Neoadjuvant Therapy of HER2+Breast Cancer","phase":"EARLY_PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":31,"lead_sponsor_name":"H. Lee Moffitt Cancer Center and Research Institute","has_results":false},{"nct_id":"NCT03137693","title":"Preoperative Stereotactic Ablative Body Radiotherapy (SABR) for Early-Stage Breast Cancer","phase":"NA","overall_status":"TERMINATED","enrollment_count":20,"lead_sponsor_name":"H. Lee Moffitt Cancer Center and Research Institute","has_results":true},{"nct_id":"NCT03834532","title":"Living Well After Breast Surgery","phase":"NA","overall_status":"COMPLETED","enrollment_count":17,"lead_sponsor_name":"University of Texas at Austin","has_results":false},{"nct_id":"NCT03112668","title":"Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their Partners","phase":"NA","overall_status":"COMPLETED","enrollment_count":14,"lead_sponsor_name":"Rutgers, The State University of New Jersey","has_results":false},{"nct_id":"NCT01217411","title":"RO4929097 and Whole-Brain Radiation Therapy or Stereotactic Radiosurgery in Treating Patients With Brain Metastases From Breast Cancer","phase":"PHASE1, PHASE2","overall_status":"TERMINATED","enrollment_count":5,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":true},{"nct_id":"NCT01706432","title":"Hypofractionated Image Guided Radiation Therapy in Treating Patients With Stage IV Breast Cancer","phase":"","overall_status":"COMPLETED","enrollment_count":4,"lead_sponsor_name":"University of Chicago","has_results":false},{"nct_id":"NCT02013492","title":"Propranolol Hydrochloride in Treating Patients With Locally Recurrent or Metastatic Solid Tumors That Cannot Be Removed By Surgery","phase":"EARLY_PHASE1","overall_status":"COMPLETED","enrollment_count":1,"lead_sponsor_name":"William Carson","has_results":false},{"nct_id":"NCT07226102","title":"Virtual Mental Health Intervention to Address Fear of Progression for Women With High Risk or Stage III-IV Gynecologic or Breast Cancer","phase":"NA","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"City of Hope Medical Center","has_results":false}],"total":32},"guidelines":[],"source":"Drug Landscape verified database"}